ATHENA: A phase 1/2 study of AZD5851, a chimeric antigen receptor (CAR) T-cell therapy directed against GPC3 in adult patients with advanced/recurrent hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | Hamilton, A.; Kelley, R. K.; Li, D.; Bermejo, I. M.; Abou-Alfa, G. K.; Alese, O. B.; Al-Rajabi, R. M. T.; Babiker, H. M.; Borad, M.; Dayyani, F.; Gutierrez, M.; Hong, J. Y.; Fonkoua, L. A. K.; Karasic, T. B.; Kardosh, A.; Keenan, B. P.; Noonan, A. M.; Saeed, A.; Bondanza, A.; Stone, J. |
| Abstract Title: | ATHENA: A phase 1/2 study of AZD5851, a chimeric antigen receptor (CAR) T-cell therapy directed against GPC3 in adult patients with advanced/recurrent hepatocellular carcinoma (HCC) |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557406098 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.TPS2675 |
| Notes: | Meeting Abstract: TPS2675 -- Source: Wos |
